2007
DOI: 10.1016/j.procbio.2007.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of gentamicin production by mutagenesis and non-nutritional stress conditions in Micromonospora echinospora

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0
4

Year Published

2007
2007
2014
2014

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 16 publications
1
9
0
4
Order By: Relevance
“…No significant variation in OTC production was detected during 4 months corresponding to eight generations. This strain appeared genetically stable as previously described for gentamycin producing M. echinospora strain (Himabindu et al 2007). …”
Section: Resultsmentioning
confidence: 96%
“…No significant variation in OTC production was detected during 4 months corresponding to eight generations. This strain appeared genetically stable as previously described for gentamycin producing M. echinospora strain (Himabindu et al 2007). …”
Section: Resultsmentioning
confidence: 96%
“…Me-22 obtained by mutagenic treatment with Ethidium bromide [6] was used in the present study. Each 250 ml Erlenmeyer flasks contained 50 ml inoculum medium having composition (g l -1 ): beef extract, 3; glucose, 1; soluble starch, 24; yeast extract, 5; CaCO 3 , 4; pH 7.6 and inoculated with Me-22 (one slant for each flask) under aseptic conditions.…”
Section: Methodsmentioning
confidence: 99%
“…We have conducted subsequent experiments to produce mutant culture of M. echinospora by different methods [6] and found that M. echinospora EtBr-22 (Me-22) was producing the maximum gentamicin concentration in shake flask experiments using production medium as defined previously [5]. The purpose of the present study was to optimize the initial concentration of carbon and nitrogen sources to study kinetic aspects of Me-22 fermentation in stirred tank reactor (STR).…”
mentioning
confidence: 99%
“…Microbial process development across the globe is increasing because of its low energy and materials consuming and eco‐friendly approach. Various microbial products have been produced by aerobic fermentations includes both primary and secondary metabolites . Antibiotics, enzymes and demand for microbial enzymes are increasing at the rate of 6.3% of per annum and are expected to reach 70 billion USD by 2013, and the rationale for such demand is due to their eco‐friendly nature for process and product development.…”
Section: Introductionmentioning
confidence: 99%